Go Pro
→ Buy THIS potential Musk supplier before Wednesday (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$34.74
-0.1%		$33.58
$27.73
▼
$35.62
$210.18M-0.02137,589 shs13,508 shs
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
C$2.00
+1.5%		C$1.53
C$1.10
▼
C$5.40
C$152.76M0.4338362,214 shs1,244 shs
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
C$0.44
+7.3%		C$0.39
C$0.34
▼
C$1.97
C$40.61M2.9688194,190 shs19,242 shs
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$26.04
+0.0%		$26.06
$25.70
▼
$26.78
$2.76B0.271.18 million shs859,890 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
0.00%+1.64%+1.55%+0.99%+24.81%
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00%+5.35%+38.73%+20.86%+45.93%
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.00%-10.87%+17.14%-8.89%-62.73%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00%-0.08%+0.42%-0.61%-2.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$34.74
-0.1%		$33.58
$27.73
▼
$35.62
$210.18M-0.02137,589 shs13,508 shs
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
C$2.00
+1.5%		C$1.53
C$1.10
▼
C$5.40
C$152.76M0.4338362,214 shs1,244 shs
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
C$0.44
+7.3%		C$0.39
C$0.34
▼
C$1.97
C$40.61M2.9688194,190 shs19,242 shs
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$26.04
+0.0%		$26.06
$25.70
▼
$26.78
$2.76B0.271.18 million shs859,890 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
0.00%+1.64%+1.55%+0.99%+24.81%
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00%+5.35%+38.73%+20.86%+45.93%
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.00%-10.87%+17.14%-8.89%-62.73%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00%-0.08%+0.42%-0.61%-2.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
0.00
N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00
N/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.00
N/AN/AN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/AN/AC$0.18 per share11.32C$0.19 per shareN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/AN/AC$0.38 per share1.15C$0.02 per shareN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
-C$50.55M-C$0.04N/AN/AN/AN/A-21.54%-279.98%N/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
-C$25.98M-C$0.22N/AN/AN/A-533,640.00%-360.29%-32.80%N/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/A60.28N/AN/AN/AN/AN/AN/A

Latest MDNA, HBP, SCYB, and COM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/25/2026Q4 2026
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/A-C$0.05N/A-C$0.05N/AN/A
6/12/2026Q3 2026
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/A-C$0.01N/A-C$0.01N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
$0.842.42%N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
N/A1.50%N/AN/AN/A
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
N/AN/AN/AN/AN/A
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
$1.796.87%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
2.44
0.45
1.04
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
6.22
1.25
4.65
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
0.00%
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
0.43%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A

Insider Ownership

CompanyInsider Ownership
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
2.15%
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
22.57%
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Direxion Auspice Broad Commodity Strategy ETF stock logo
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A6.05 millionN/ANot Optionable
Helix BioPharma Corp. stock logo
HBP
Helix BioPharma
976.38 millionN/ANot Optionable
Medicenna Therapeutics Corp. stock logo
MDNA
Medicenna Therapeutics
2092.30 millionN/ANot Optionable
Schwab High Yield Bond ETF stock logo
SCYB
Schwab High Yield Bond ETF
N/A106.00 millionN/ANot Optionable

Recent News About These Companies

Schwab high yield bond ETF declares monthly distribution of $0.1547
August 3, 2026  |  msn.comhttps://www.msn.com/en-us/money/investment/schwab-high-yield-bond-etf-declares-monthly-distribution-of-0-1547/ar-AA29kjxo
SCYB: A Low-Cost High-Yield Allocation For Both Tactical And Complementary Portfolios
July 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4927154-scyb-a-low-cost-high-yield-allocation-for-both-tactical-and-complementary-portfolios
Schwab high yield bond ETF declares $0.1487 dividend
July 2, 2026  |  msn.comhttps://www.msn.com/en-us/money/mutualfunds/schwab-high-yield-bond-etf-declares-01487-dividend/ar-AA270jJ9
SCYB My Choice Among High Yield ETFs
May 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4904826-scyb-my-choice-among-high-yield-etfs
Schwab high yield bond ETF declares monthly distribution of $0.1449
May 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01449/ar-AA22awNQ
Schwab High Yield Bond ETF declares monthly distribution of $0.1537
April 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01537/ar-AA1ZVARm
SCYB: Trouble Not Yet Boiling Over In High Yield
March 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4876835-scyb-trouble-not-yet-boiling-over-in-high-yield
Schwab high yield bond ETF declares monthly distribution of $0.1481
December 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/schwab-high-yield-bond-etf-declares-monthly-distribution-of-01481/ar-AA1SGRyi
High-Yield Confidence: Advisors Lean Into Credit in the New Year
December 15, 2025  |  etftrends.comE
SCYB: Cheapest High-Yield Bond ETF, But Not A Buy Right Now (Rating Downgrade)
December 12, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4853084-scyb-cheapest-high-yield-bond-etf-but-not-a-buy-right-now
SCYB: An Ultra-Low-Cost High Yield ETF To Harvest Carry In A Stable-Price Scenario
December 11, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4852518-scyb-an-ultra-low-cost-high-yield-etf-to-harvest-carry-in-a-stable-price-scenario
Schwab High Yield Bond ETF declares monthly distribution of $0.1498
October 1, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/schwab-high-yield-bond-etf-declares-monthly-distribution-of-0-1498/ar-AA1NGeLW
SCYB: An Appealing Low-Cost, High-Yield Bond Portfolio
September 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4826609-scyb-an-appealing-low-cost-high-yield-bond-portfolio
CSE Bulletin: Consolidation - Scryb Inc. (SCYB)
August 11, 2025  |  newsfilecorp.comN
SCYB: Passive High Yield ETF From Schwab
July 16, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4801515-scyb-passive-high-yield-etf-from-schwab
Schwab High Yield Bond ETF declares $0.1527 dividend
July 1, 2025  |  msn.comhttps://www.msn.com/en-us/money/mutualfunds/schwab-high-yield-bond-etf-declares-01527-dividend/ar-AA1HLJ78
7 Lowest Expense Ratio ETFs
June 10, 2025  |  money.usnews.comhttps://money.usnews.com/investing/articles/lowest-expense-ratio-etfs
SCYB: Not The Time For High Yield
May 4, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4781628-scyb-not-time-for-high-yield
Schwab High Yield Bond ETF declares $0.1586 dividend
May 2, 2025  |  seekingalpha.comhttps://seekingalpha.com/news/4440260-schwab-high-yield-bond-etf-declares-0_1586-dividend?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=news?source=MarketBeat
Schwab High Yield Bond ETF (SCYB) Dividend History
March 29, 2025  |  nasdaq.comhttps://www.nasdaq.com/market-activity/etf/scyb/dividend-history

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Composite image of commodities including gold bars, an oil pumpjack, copper wire coils, wheat, and corn kernels.
Commodities Are Booming, But These 3 ETFs Tell Different Stories
By Nathan Reiff | August 17, 2026
Ulta Beauty logo illuminated on a backlit display surrounded by makeup products, brushes, and cosmetics on a countertop.
Ulta's Growth Is Real, But So Are the Risks
By Peter Frank | August 5, 2026
Illuminated Nasdaq logo displayed on a glass building facade, with city skyscrapers reflected around it.
Nasdaq’s 23-Hour Trading Push Could Turn Global Liquidity Into a Growth Engine
By Jeffrey Neal Johnson | August 20, 2026
Direxion Auspice Broad Commodity Strategy ETF stock logo

Direxion Auspice Broad Commodity Strategy ETF NYSEARCA:COM

$34.74 -0.02 (-0.06%)
As of 02:36 PM Eastern

The Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.

Helix BioPharma stock logo

Helix BioPharma TSE:HBP

C$2.00 +0.03 (+1.52%)
As of 11:55 AM Eastern

Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today's hardest-to-treat cancers. The Company's pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today's front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix's next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery. The Company also advances two pre-IND candidates: (i) LEUMUNA¿, an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and (ii) GEMCEDA¿, a first-in-class oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers.

Medicenna Therapeutics stock logo

Medicenna Therapeutics TSE:MDNA

C$0.44 +0.03 (+7.32%)
As of 02:13 PM Eastern

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients.

Schwab High Yield Bond ETF stock logo

Schwab High Yield Bond ETF NYSEARCA:SCYB

$26.04 +0.01 (+0.04%)
As of 02:40 PM Eastern

The Schwab High Yield Bond ETF (SCYB) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks an index of USD-denominated high-yield, US corporate bonds, selected and weighted based on market value. SCYB was launched on Jul 11, 2023 and is managed by Charles Schwab.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas